Ironwood Pharmaceuticals | IRWD - Market Capitalization

Stock Price
3.58
Daily Change
-0.09 -2.45%
Monthly
-17.32%
Yearly
528.07%
Q2 Forecast
3.51

Ironwood Pharmaceuticals reported $574.5M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Almirall EUR 2.51B 251.72M May/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amarin USD 290M 51M Dec/2025
Astellas Pharma JPY 4.56T 770.92B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Charles River Laboratories USD 9.29B 1.44B May/2026
Coherus Biosciences USD 172M 19M Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 8.44B 781M May/2026
Incyte USD 21.73B 3B May/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
MacroGenics USD 102M 4M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Myriad Genetics USD 575M 98M Dec/2025
Pacira USD 915M 149M Mar/2026
PTC Therapeutics USD 4.94B 698M May/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Takeda JPY 8.33T 681.01B May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024